CDSCO monthly lab alert
CDSCO NSQ alert, November 2025: 216 drug batches flagged
By Blacklisted editorial team· Published 20 Dec 2025· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its November 2025 alert, the Central Drugs Standard Control Organisation listed 216 drug batches that failed quality tests, 64 at central laboratories and 152 at state drug-testing laboratories, from 174 manufacturers across 149 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Calcium Phosphate & Vitamin D3 Suspension, Telmisartan Tablets IP 40 mg, Telmisartan & Amlodipine Tablets IP.
216
Batches flagged
64 / 152
Central / state labs
Assay
Top reason
174
Manufacturers
Batches per month, last 12 alerts
Dec 2024Nov 2025 · 216
Full list of NSQ batches, November 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| �(Cyproheptadine Hydrochloride & Tricholine Citrate syrup) | MDL-B641Mfg 2024-11 · Exp 2026-10 | Marvellon Pharmaceuticals Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Zedrest-Plus | VDET-288Mfg 2023-12 · Exp 2025-11 | Vzoic Healthcare Pvt. LtdPunjab | Disintegration TestDisintegration | SDT&RL, BhubaneswarState lab |
| Voglibose Tablets IP 0.3mg | LC25D111AMfg 2025-04 · Exp 2027-03 | Lifecare Neuro Products Ltd. 70/1Himachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Trypsin-Chymortypsin Tablets | 2KU6L012Mfg 2024-02 · Exp 2027-01 | Torrent Pharmaceuticals LtdSikkim | Enzymatic Activity (Trypsin & Chymotrypsin) and Disintegration (Acid stage)Disintegration | Food & Drugs Laboratory, VadodaraState lab |
| Tramadol & Paracetamol Tablets IP | BT-1322Mfg 2025-03 · Exp 2027-02 | Badrivas Biotech Pvt. LtdUttarakhand | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Terbutaline Sulphate, Ambroxol Hydrochloride & Choline Theophylinate | SR-10Mfg 2025-05 · Exp 2028-04 | Sresan Pharmaceutical ManufacturerKarnataka | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 80 mg | TST 4510Mfg 2025-08 · Exp 2027-07 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| Telmisartan Tablets IP 40 mg | BPLT-24302Mfg 2024-10 · Exp 2026-09 | Bennet Pharmaceuticals Ltd. Village Chanal MajraHimachal Pradesh | The sample does not conform to IP with respect to the reason stated under Description.Description | CDTL,IndoreCDSCO lab |
| Telmisartan Tablets IP 40 mg | ED24290Mfg 2024-09 · Exp 2026-08 | Elfin Drugs Pvt. Ltd. Vill.-BersonHimachal Pradesh | The sample is declared to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Telmisartan Tablets IP 40 mg | ED25088Mfg 2025-07 · Exp 2027-06 | Elfin Drugs Pvt. Ltd. Vill.-BersonHimachal Pradesh | The sample is declared to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Telmisartan & Hydrochlorothizide Tablets IP | B25X021Mfg 2024-12 · Exp 2026-11 | Mankind Pharma LtdSikkim | test for Dissolution of Telmisartan onlyDissolution | RDTL, Hubli, KarnatakaState lab |
| Telmisartan & Amlodipine Tablets IP | MLS-241413Mfg 2025-01 · Exp 2026-12 | Maskon Life Sciences Pvt. Ltd. Khasra No. 69-KhatakhenUttarakhand | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Telmisartan & Amlodipine Tablets IP | TGT296AMfg 2024-07 · Exp 2026-06 | Amster Labs LimitedHimachal Pradesh | Dissolution (For Telmisartan)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Tablets of Supator-20 (AtorvastatinTablets IP 20mg) | SRTB240152Mfg 2024-02 · Exp 2026-01 | Systole Remedies Pvt. Ltd. Vill-OgliHimachal Pradesh | Content of AtorvastatinOther | SDT&RL, BhubaneswarState lab |
| Tablets of Glimepiride Tablets I.P.2mg | SGO-103Mfg 2025-01 · Exp 2026-12 | MARC LIFESCIENCESSikkim | DescriptionDescription | SDT&RL, BhubaneswarState lab |
| Sucralfate and Oxetacaine Suspension | L250813Mfg 2025-08 · Exp 2027-07 | SGS Formulation Pvt Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Sucralfate & Oxetacaine Suspension | SCO-2503Mfg 2025-06 · Exp 2027-05 | Apple Formulations Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Sucralfate & Oxetacaine Oral Suspension | JLD25C14AMfg 2025-03 · Exp 2027-02 | Jaiwik Biotech (P) LtdRajasthan | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Sterile Water For Injection I.P | W25010Mfg 2025-04 · Exp 2028-03 | Vivek Pharmaceuticals Pvt. LtdJammu & Kashmir | BETOther | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Spoorthi Aloegramflour Soap | 6Mfg 2024-06 · Exp 2027-05 | Spoorthi Herbals No.:299Karnataka | Test for Matter Insoluble in Alcohol onlyOther | RDTL, Hubli, KarnatakaState lab |
| Sorbitol Solution 70% IP | KA/018Mfg 2025-09 · Exp 2030-08 | Gujarat Ambuja Exports LtdGujarat | Ethylene Glycol-0.144% (Limit-0.1%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Sorbitol 70% IP | KA/018Mfg 2025-09 · Exp 2030-08 | Gujarat Ambuja Exports LtdGujarat | Ethylene Glycol-0.154% (Limit-0.1%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Sodium Valproate and Valproic Acid Controlled Release Tablets | ST-240134Mfg 2024-01 · Exp 2025-12 | Supermax Drugs & Drugs Pharmaceuticals Pvt. Ltd. (Unit-II) Khasra No-322Uttarakhand | DescriptionDescription | SDT&RL, BhubaneswarState lab |
| Sodium Valproate Tablets IP 300 mg | RG24129TMfg 2024-03 · Exp 2026-02 | Rescures LIfe Sciences Ltd. 131-132 EPIP Phase-1Himachal Pradesh | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Sodium Valproate Gastro-resistant Tablets I.P. 200 mg. | 425-263Mfg 2025-01 · Exp 2026-12 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Sodium Valproate Gastro resistant Tablets IP 200 mg. | 03637Mfg 2024-03 · Exp 2026-02 | Healthy Life Pharma Pvt. Ltd. Factory : N-31/1Maharashtra | The sample is not of standard quality for the reason stated under "Description" of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Sodium Valproate & Valproic Acid Controlled Release Tablets | ADT25196BMfg 2025-01 · Exp 2026-12 | Astonea Labs Limited Vill. HaripurHaryana | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium ValproateAssay | RDTL,ChandigarhCDSCO lab |
| Simethicone Oral Suspension U.S.P | 1503Mfg 2025-03 · Exp 2027-02 | Pulse Pharma Mfg. CoGujarat | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Restol 650 | BT-2953Mfg 2024-10 · Exp 2027-09 | Biosearch Organics(An ISO 9001;2015 Certified Co.) D.I.C Ind.Estate | Thesample does not conform to I.P w.r.t the test for," Dissolution"Dissolution | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Ranitidine Oral Solution IP | SR-017Mfg 2024-06 · Exp 2026-05 | Sresan Pharmaceutical ManufacturerKarnataka | This particular batch of sample fails the test Assay of Ranitidine.Assay | RDTL ErnakulamState lab |
| Ranitidine Oral Solution IP | AL24011221DMfg 2024-01 · Exp 2025-12 | Accura Care Pharmaceuticals Pvt. LtdHimachal Pradesh | Content of RanitidineOther | SDT&RL, BhubaneswarState lab |
| Ranitidine Hydrochloride Tablets IP 150mg | AZCT-2505Mfg 2025-05 · Exp 2027-04 | SELDOM PHARMA PVT.LTD #6-8-122Puducherry | Circular orange colored, biconvex plain on both sides. Two types of colored tablets observed while opening from the strips. Some tablets are light brown colored and some tablets are orange colored, hence Description (Appearance) test parameter does not complies as per IP specification.Description | DCL TelanganaState lab |
| Ramipril Tablets IP 5 mg | TGT25-165Mfg 2025-07 · Exp 2027-06 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Ramipril Tablets IP 2.5 mg | PT-44206Mfg 2024-12 · Exp 2026-11 | Pharmaroots HealthcareHimachal Pradesh | Test for Dissolution & Assay for RAmiprilAssay | RDTL, Hubli, KarnatakaState lab |
| Ramipril Tablets IP | SD-1457Mfg 2025-07 · Exp 2027-06 | Sano-Cito Therapeutics Inc. Vill LoharanHimachal Pradesh | The sample does not conform to the IP with respect to Assay and DissolutionAssay | DTL, JaipurState lab |
| Ramipril Tablets IP | GVD0644Mfg 2025-01 · Exp 2025-12 | Ved Lifesavers (P) LtdUttarakhand | The sample does not conform to the claim with respect to Assay & DissolutionAssay | DTL, JaipurState lab |
| Ramipril & Metoprolol Succinate Sustain Release Tablets | T24K554AMfg 2024-11 · Exp 2026-10 | Bajaj Formulation Khasra No. 161Uttarakhand | The sample does not conform to the claim with respect to Assay of RamipriAssay | DTL, JaipurState lab |
| Rabeprazole Sodium Injection IP 20mg/vial | MD25B18Mfg 2025-02 · Exp 2027-01 | Martin & Brown Bio-Sciences Pvt. Ltd. K.No 918/419Himachal Pradesh | The sample does not conform to I.P with respect to test for "Clarity of solution", "Particulate matter", "Sterility" and "Description".Description | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (Enteric Coated) & Domperidone (SR) Capsules | ICK0222Mfg 2024-09 · Exp 2026-08 | Innova Captab LtdHimachal Pradesh | The sample does not conform to Manufacturer Specification with respect to the Assay of Rabeprazole Sodium.Assay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium (EC)n & Dompoeridone SR Capsule | C011H03Mfg 2024-06 · Exp 2026-05 | Bioconic RemediesHimachal Pradesh | Rabeprazole content-75.01 %Other | Food & Drugs Laboratory, VadodaraState lab |
| Rabeprazole Sodium Tablets IP 20mg, | T25.018Mfg 2025-06 · Exp 2026-12 | Oaksun LifesciencesTelangana | It fails the test "Dissolution". as per IP, as specified in the Laboratory Protocol.Dissolution | DTL KonniState lab |
| Rabeprazole & Domperidone Capsules | ORECA-004Mfg 2024-04 · Exp 2026-03 | Laborate Pharmaceuticals India Ltd (Unit-ii) 31Himachal Pradesh | Rabeprazole & Domperidone Capsules does not comply Rabeprazole sodium Assay as per STPAssay | DCL TelanganaState lab |
| Prednisolone Acetate Opthalmic Suspension USP | 2.4000000000000001E+29Mfg 2024-05 · Exp 2026-04 | Contacare Ophthalmics and DiagnosticsGujarat | Assay for Predniosolone acetateAssay | DTL, Bengaluru, KarnatakaState lab |
| Povidone-Iodine Solution IP 10%w/v | 121Mfg 2024-07 · Exp 2026-06 | Algen Healthcare Ltd 134/2Himachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for pH of Povidone-Iodine Solution.pH | RDTL, GuwahatiCDSCO lab |
| Povidone - Iodine & Metronidazole Ointment | 5C10Mfg 2025-03 · Exp 2027-02 | Zenith Drugs LimitedMadhya Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Potassium Chloride Liquid 200 ml | 957Mfg 2025-04 · Exp 2027-03 | Sunny Industries Private Ltd. 23/3/1BWest Bengal | The sample does not conform to Manufacturers Specification with respect to the test of pH.pH | CDL, KolkataCDSCO lab |
| Polygeline Intravenous Infusion (3.5% w/v Polygeline colloidal solution with electrolytes) | 24EPT019Mfg 2024-11 · Exp 2026-10 | Pentagon Labs Ltd. 16C/16D | The sample does not conform to claim as per Patent and Proprietary (RDTL/MS/4136) in respect to the Test of Particulate matter, Assay of Potassium and Total Chloride.Assay | RDTL,ChandigarhCDSCO lab |
| Pheniramine Maleate Injection I.P. | 2123054Mfg 2023-06 · Exp 2026-05 | Sanofi India Ltd. Plot No. 1175Gujarat | The sample does not conform to IP with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Paracetamol, Phenylephrine HCl & Chlorpheniramine Maleate Suspension | IHP0047Mfg 2025-08 · Exp 2027-07 | Infiniheal PharmaceuticalsGujarat | Total Aerobic Microbial CountMicrobial limits | Food & Drugs Laboratory, VadodaraState lab |
| Paracetamol and Tramadol Hydrochloride Tablets IP | LBHK25001Mfg 2025-02 · Exp 2028-01 | Chimak Health careHimachal Pradesh | The sample does not conform to IP Standards with respect to Dissolution.Dissolution | DTL ThrissurState lab |
| Paracetamol Tablets IP 650mg | TEM24011ALMfg 2024-10 · Exp 2026-09 | Hindustan Laboratories LimitedMaharashtra | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Paracetamol Tablets IP 650 mg) | DT2502044CMfg 2025-02 · Exp 2027-01 | IndoRama Health Care Pvt. LtdHaryana | Test for Dissolution" and "DescriptionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP 650 mg | PCT25093Mfg 2025-05 · Exp 2027-04 | Vivek Pharmachem (India) LtdRajasthan | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP 500 | GPL23033Mfg 2023-08 · Exp 2026-07 | IBN Herbals (A Unit of Curetech Formulations (P) Ltd) Khasara No. 63Himachal Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Paracetamol Tablets IP - 650 mg | 1515Mfg 2025-03 · Exp 2028-02 | ALPHA PHARMACEUTICALS 41Haryana | The sample does not conform to I.P With respect to test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Paracetamol Tablets IP | SPT-9584AMfg 2024-11 · Exp 2026-10 | Shivani Pharmaceuticals Plot No.149Himachal Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Paracetamol Paediatric Syrup IP | SP-684Mfg 2024-11 · Exp 2026-11 | South East pharmaceuticalsTamil Nadu | Impurity (EG) Limit:Not More than 0.1%, Present-0.385%Other | Drugs Testing Laboratory, Chennai-06State lab |
| Paracetamol Paediatric Syrup IP | SP-683Mfg 2024-11 · Exp 2026-11 | South East pharmaceuticalsTamil Nadu | Impurity (EG) Limit:Not More than 0.1%, Present-0.4%Other | Drugs Testing Laboratory, Chennai-06State lab |
| Pantoprazole Tablets IP 40mg. | N2501055Mfg 2025-03 · Exp 2028-02 | Intas Pharmaceuticals LtdSikkim | The sample does not conform to I.P with respect to the test for "Dissolution in Buffer Stage:.Dissolution | CDTL,IndoreCDSCO lab |
| Pantoprazole Tablets IP 40 mg | 25A-T126BMfg 2025-04 · Exp 2027-03 | Orison Pharma International ( A WHO: GMP Certified Company) Vill Khari Mauza OgliHimachal Pradesh | The sample does not conform to I.P 2022 requirements w.r.t the test for," Dissolution"Dissolution | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | SPA250021Mfg 2025-01 · Exp 2026-12 | ARISTO Pharmaceuticals Pvt. Ltd. Plot Nos.: 2040-46Sikkim | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Assay of Pantoprazole Sodium calculated as Pantoprazole, Domperidone.Assay | RDTL,ChandigarhCDSCO lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | CHPLT672Mfg 2025-01 · Exp 2026-12 | Cureza Healthcare Pvt. Ltd. 63/1Madhya Pradesh | The sample does not conform to IP with respect to test for "Dissolution" and "Description".Dissolution | CDL, KolkataCDSCO lab |
| Omeprazole Capsule IP 20 mg | 153/25Mfg 2025-01 · Exp 2026-12 | Aban PharmaceuticalsKerala | Dissolution ( Buffer satage)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Ofloxacin and Ornidazole Tablets IP | VT250644Mfg 2025-06 · Exp 2027-05 | VADSP Pharmaceuticals Plot No.-124 E.P.I.P. Ind. Area Phase-1Himachal Pradesh | The sample does ot conforms to claim as per IP 2022 in respect to the Test of Dissolution of Ofloxacin & Ornidazole.Dissolution | DTL, BADDI H.PState lab |
| Ofloxacin Tab IP 200mg | YLT25025Mfg 2025-06 · Exp 2027-05 | YL PharmaHimachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Nitrazepam Tablets IP 10mg | AXZ24003PMfg 2024-01 · Exp 2028-06 | Anglo-French Drugs & Industries Ltd. Plot No. 4Karnataka | The sample does not give IP identification for the presence of Nitrazepam, The sample is decalred as spuriousIdentification | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| Nifedipine Sustained Release Tablets IP 20 mg | 3442505Mfg 2025-07 · Exp 2027-06 | Towa Pharma Private Limited | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Nifedipine Sustained Release Tablets IP 10 mg | T250809Mfg 2025-08 · Exp 2027-07 | Medisky Pharmaceuticals Pvt.Ltd | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Naltrexone HCL Tablets IP 50 mg | T2507109Mfg 2025-07 · Exp 2027-06 | Micron Pharmaceuticals | Brittle TabletsOther | Food & Drugs Laboratory, VadodaraState lab |
| Naltrexone HCL Tablets IP 50 mg | T250651Mfg 2025-06 · Exp 2027-05 | Micron Pharmaceuticals | Brittle TabletsOther | Food & Drugs Laboratory, VadodaraState lab |
| Montelukast & Levocetirizine Tablets IP | LCM-5061Mfg 2025-06 · Exp 2027-05 | Spinka PharmaTelangana | This particular batch of sample fails the test Dissolution of Montelukast.Dissolution | RDTL ErnakulamState lab |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension | LXFPL606Mfg 2024-12 · Exp 2026-11 | Tulbros Formulations | Description onlyDescription | RDTL, Hubli, KarnatakaState lab |
| Metronidazole Tablets IP 400mg | RMTT-049Mfg 2025-09 · Exp 2027-08 | Revat Laboratories Pvt. Ltd. 12-321 | The sample received does not conform to IP 2022, IP Addendum 2024 specification with respect to the description only.Description | CDTL,HyderabadCDSCO lab |
| Metronidazole Tablets IP 200 mg | MZ241004Mfg 2024-10 · Exp 2026-09 | Cipcoo Pharmaceuticals 35-36/1Madhya Pradesh | Sample does not comply Dissolution parameter as per Metronidazole Tablets IP of IP 2022.Dissolution | DCL TelanganaState lab |
| Metoprolol Injection IP | DAB004Mfg 2025-04 · Exp 2027-03 | Dial PharmaceuticalsGujarat | Bacterial Endotoxins & SterilitySterility | Food & Drugs Laboratory, VadodaraState lab |
| Methylprednisolone Tablets IP 4mg | TGT25-091Mfg 2025-04 · Exp 2027-03 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Metformin Hydrochloride Tablets IP 1000 mg | DL-60Mfg 2024-10 · Exp 2026-09 | Dutch Formulations 32Himachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test Uniformity of weight and Assay of Metformin Hydrochloride.Assay | RDTL,ChandigarhCDSCO lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P. | VPP11224Mfg 2024-12 · Exp 2026-11 | Suraksha Pharma Pvt LtdUttarakhand | The sample received does not conform to I.P. 2022 specification with respect to the description only.Description | CDTL,HyderabadCDSCO lab |
| Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P (500mg/2mg) | PRT-250235Mfg 2025-02 · Exp 2027-01 | Preet Remedies (P) LtdHimachal Pradesh | Dissolution test for GlimepirideDissolution | RDTL, Bellary, KarnatakaState lab |
| Meropenam Injection IP 500 mg | PMI3519Mfg 2025-06 · Exp 2027-05 | Modern LaboratoriesMadhya Pradesh | bacterial EndotoxinsBacterial endotoxins | Food & Drugs Laboratory, VadodaraState lab |
| Mecobalamin Tablets 1500 mcg | ILM-56002Mfg 2025-07 · Exp 2027-06 | Sain Medicaments Pvt. Ltd. P-2/4Telangana | The sample does not comply with the test for Disintegration for oral dissolving tablets. Out of 18 tablets, only two tablets disintegrated within 3 minutes in water. Hence the sample does not comply with the test for disintegration.Disintegration | DCL TelanganaState lab |
| Mebeverine Hydrochloride and Chlordiazepoxide Tablets | NTE0566AMfg 2024-09 · Exp 2026-08 | Digital Vision 176Himachal Pradesh | The sample does not conform to claim with respect to the tests of Disintegration, Assay of Mebeverine Hydrochloride and Assay of Chlordiazepoxide.Assay | CDL, KolkataCDSCO lab |
| Lexof-O+ (Ofloxacin, Ornidazole & Saccharomyces Boulardii Tablets) | T25C442AMfg 2025-03 · Exp 2027-02 | Bajaj FormulationUttarakhand | Test for Uniformity of Weight onlyUniformity of weight/content | RDTL, Hubli, KarnatakaState lab |
| Levosalbutamol, Ambroxol HCL & Guaiphenesin Syrup | XL983Mfg 2024-09 · Exp 2026-08 | Saphnix Life SciencesHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Levosalbutamol Sulphate, Ambroxol HCl & Guaiphensin Syrup | SP25195Mfg 2025-03 · Exp 2027-02 | Seejar Pharmaceuticals | Assay for Guaiphenesin and Ambroxol HydrochlorideAssay | DTL, Bengaluru, KarnatakaState lab |
| Levosalbutamol Sulphate Syrup 1mg/5ml | L24/0639AMfg 2025-03 · Exp 2027-02 | Samkem 15-B & 10-BMadhya Pradesh | The sample received does not conform to manufactures specification with respect to the test for assay only.Assay | CDTL,HyderabadCDSCO lab |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets | YLT25029Mfg 2025-09 · Exp 2027-08 | YL PharmaHimachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Levocetirizine DiHydrochloride Tablets | YLT25028Mfg 2025-07 · Exp 2027-06 | YL PharmaHimachal Pradesh | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Lactulose Solution USP | JL-240147Mfg 2024-10 · Exp 2026-09 | Jineka Healthcare Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ketorolac Tromethamine Tablets IP 10mg | TGT25-096Mfg 2025-04 · Exp 2027-03 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Itraconazole Capsule IP 100mg | 1725-230Mfg 2025-04 · Exp 2027-09 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conforrm to the IP with respect to DissolutionDissolution | DTL, JaipurState lab |
| Iron Sucrose Injection USP 100mg/5ml | 24RS14Mfg 2024-12 · Exp 2026-11 | SAI Parenterals LimitedTelangana | The sample does not conform to U.S.P with respect to test for pH and AlkalinitypH | CDL, KolkataCDSCO lab |
| Ibuprofen Tablets I.P. 400 mg | INT 3504Mfg 2025-08 · Exp 2027-07 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| Ibuprofen Tablets I.P. 400 mg | INT 3505Mfg 2025-08 · Exp 2027-07 | Modern LaboratoriesMadhya Pradesh | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| IRON AND FOLIC ACID TABLETS IP (Iron 60mg and Folic acid 0.5mg) | IQTB-39Mfg 2024-01 · Exp 2025-12 | Nestor Pharmaceuticals LimitedHaryana | Uniformity of Content & Assay for Folic AcidAssay | SDT&RL, BhubaneswarState lab |
| INFUSION SET-NV | KT-046Mfg 2024-04 · Exp 2027-03 | Medivision Healthcare 84/4 Span Industrial complex.Second FloorGujarat | The sample does not comply as per IP 2022 & IS 12655 (Part 4): 2003 with respect to the tests for "Sterility and Packaging" of the Infusion sets.Sterility | RDTL, GuwahatiCDSCO lab |
| IBUT Plus | T5863Mfg 2024-02 · Exp 2027-01 | Leben Laboratories Pvt.Ltd.Office;11Maharashtra | The sample does not conform to I.P 2022 requirements w.r.t the test for," Dissolution"Dissolution | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Hydroxyzine HCL Oral Solution IP 10 mg | R09GL2545AMfg 2025-09 · Exp 2027-08 | Rednex Pharmaceuticals Limited Survey No : 586 & 231Gujarat | The sample received does not conform to I.P. 2022 with respect to the test for pH..pH | CDTL, MumbaiCDSCO lab |
| Hydrogen Peroxide Topical Solution USP 3% w/v 10 Vol | HP/19/25Mfg 2025-04 · Exp 2026-09 | Prem Laboratories D.No. 16-9-749/36/BTelangana | Sample does not comply assay and acidity parameters as per USP.Assay | DCL TelanganaState lab |
| Glimepiride, Pioglitazone Hydrochloride and Metformin Hydrochloride Sustained-release Tablets (2mg/15mg/500mg) | GMPT-1050Mfg 2024-01 · Exp 2025-12 | Wings Biotech LLPHimachal Pradesh | Assay for Glimepiride" onlyAssay | RDTL, Hubli, KarnatakaState lab |
| Glimepiride, Metformin Hydrochloride (SR) and Voglibose Tablets | SSGT-2401Mfg 2024-10 · Exp 2026-09 | Verax Life Sciences Pvt. LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Glimepiride Tablets IP.2mg | GP08Mfg 2024-09 · Exp 2027-08 | Mahendra Labs Pvt. LtdKarnataka | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab |
| Glimepiride Tablets IP 2mg | GL 4142Mfg 2024-11 · Exp 2026-10 | Kerala State Drugs and Pharmaceuticals LtdKerala | It fails the test "Dissolution". as per IP.Dissolution | DTL ThrissurState lab |
| Glimepiride Tablets IP 2mg | TGT25-090Mfg 2025-04 · Exp 2027-03 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| Glimepiride Tablets IP 1 mg | TA24826Mfg 2024-10 · Exp 2026-09 | Saintlife Pharmaceuticals LtdUttarakhand | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab |
| Gentamicin Sulphate Injection I.P | MA25C13Mfg 2025-03 · Exp 2027-02 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | Assay for GentamicinAssay | DTL, Bengaluru, KarnatakaState lab |
| Gastro-Resistant Omeprazole Capsules BP 10 mg | C-3023Mfg 2024-10 · Exp 2026-04 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample does not conform to claim as per B.P. in respect to the Test of Dissolution (Final Stage, PH 6.8)Dissolution | CDL, KolkataCDSCO lab |
| GLYCERIN I.P | RPE011Mfg 2025-07 · Exp 2028-06 | The Swastik PharmaceuticalsAndhra Pradesh | The sample does not conform to standard quality in respect of the test for "Assay" performed.Assay | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP(2mg + 500 mg) | G522501BMfg 2025-02 · Exp 2027-01 | Lifecare Formulations Pvt. LtdPuducherry | Assay (for GLIMEPIRIDE)Assay | DTL, PuducherryState lab |
| Folic Acid Tablets IP 5 mg | CH24223Mfg 2024-11 · Exp 2026-10 | Chalice Vitalchem Pvt. Ltd. Khasra no. 232Himachal Pradesh | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Dissolution.Dissolution | RDTL,ChandigarhCDSCO lab |
| Folic Acid Tablets IP | FTV25002Mfg 2025-03 · Exp 2027-02 | Danish Healthcare P Ltd | Description & DissolutionDissolution | Food & Drugs Laboratory, VadodaraState lab |
| Fluorometholone Ophthalmic Solution USP | E240423AMfg 2024-04 · Exp 2026-03 | Oscar Remedies Pvt. Ltd | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Ferrous Ascorbate, Folic Acid & Zinc Tablets | MMT-11855Mfg 2024-12 · Exp 2026-05 | Mayford Pharma Near Railway crossingHimachal Pradesh | Assay of Elemental Iron does not comply as per STP and as per IP 2022 the label should state the strength in terms of Ferrous ascorbate equivalent to Elemental Iron, but Ferin-XT tablets label is not mentioned Ferrous Ascorbate equivalent to Elemental Iron. Hence sample deemed to be Misbranded as per Section 17 of D & C act 1940.Assay | DCL TelanganaState lab |
| Ferric Carboxymaltose Injection 50 mg/ml | BI240239AMfg 2024-12 · Exp 2026-11 | BDR Pharmaceuticals Intl Pvt. Ltd. Vanseti Village | The sample does not conform to Manufacturer Specification with respect to the Test of Particulate matterParticulate matter | CDL, KolkataCDSCO lab |
| Enteric Coated Rabeprazole Sodium&Domperidone Sustained Release Capsules | C-24186Mfg 2024-08 · Exp 2026-07 | Sunlife Sciences 130Uttarakhand | Enteric Coated Rabeprazole & Domperidone sustained Release Capsules does not comply Assay of Rabeprazole sodium as per STP.Assay | DCL TelanganaState lab |
| EMIZ PLUS | GT-25017Mfg 2025-03 · Exp 2027-02 | Green Enviro CoHimachal Pradesh | Orally disintegrating tablets (ODT)Other | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Dried Aluminium Hydroxide Gel, Magnesium Hydroxide and Simethicone Suspension IP | ECL/25/146Mfg 2025-06 · Exp 2027-05 | Emmchak Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Dried Aluminium Hydroxide Gel I.P. 250 mg | 25001Mfg 2025-05 · Exp 2027-04 | Diamond Drugs Pvt. Ltd 94West Bengal | The sample does not conform to claim as per Manufacturers Spec in respect of the test Assay for Sorbitol.Assay | CDL, KolkataCDSCO lab |
| Doxycycline Hydrochloride Capsule IP 100 mg | C5009Mfg 2025-07 · Exp 2027-06 | Zest PharmaMadhya Pradesh | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Doxycycline Hydrochloride Capsule IP 100 mg | C5007Mfg 2025-07 · Exp 2027-06 | Zest PharmaMadhya Pradesh | Dissolution (Doxycycline)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Doxycycline Capsules IP100mg | C50174Mfg 2025-05 · Exp 2027-04 | Zenith Drugs LimitedMadhya Pradesh | UniformityUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Dicyclomine Tablets IP 10mg | DC24002Mfg 2024-11 · Exp 2026-10 | EUROKEM Laboratories Pvt.Ltd. C-25Tamil Nadu | Tablets are not intact condition. when strip is opended, tablets found to be in powdered state. Hence Dicyclomine tablets does not meet the Specifications Wrt. DescriptionDescription | DCL TelanganaState lab |
| Diclofenac Sodium Tablets IP 50 mg | B250895Mfg 2025-06 · Exp 2027-05 | Bochem Healthcare Pvt. Ltd | Dissolution (Buffer stage)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Dextromethorphan Hydrobromide, Paracetamol & Phenylephrine HCl Suspension | IHP0022Mfg 2025-05 · Exp 2027-04 | Infiniheal PharmaceuticalsGujarat | Total Aerobic Microbial CountMicrobial limits | Food & Drugs Laboratory, VadodaraState lab |
| Dextromethorphan Hydrobromide Syrup IP. | 1B0453Mfg 2026-07 · Exp 2027-06 | Deep Pharma Unit-2Gujarat | The sample received does not conform to I.P. 2022 with respect to the test for Microbial limit testMicrobial limits | CDTL, MumbaiCDSCO lab |
| Dexamethasone Tablets IP 0.5mg | TA24660Mfg 2024-08 · Exp 2026-07 | Saintlife Pharmaceuticals LtdUttarakhand | DefinitionOther | Drugs Testing Laboratory, Chennai-06State lab |
| Deflazacort Tablets | TGT25-092Mfg 2025-04 · Exp 2027-03 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab |
| DICLOFENAC DIETHYLAMINE , MENTHOL & METHYLSALICYLATE LINIMENT | 677Mfg 2025-03 · Exp 2026-08 | .M/S Argion Cosmed India Pvt LtdTamil Nadu | Assay (for Methylsalicylate)Assay | DTL, PuducherryState lab |
| DIAZEPAM INJECTION IP -2ml | DA-2411Mfg 2024-04 · Exp 2026-03 | Systochem Laboratories Ltd. B-75 Roop Nagar | The sample does not conform to I.P. with respect to the tests of Identification of Diazepam, pH, Particulate Matter, Sterility, Assay of Diazepam and Description.Assay | CDL, KolkataCDSCO lab |
| DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP | 3261Mfg 2024-09 · Exp 2026-08 | Apshsri PharmaceuticalsTamil Nadu | Assay (for Phenylephrine Hydrochloride and Chlorpheniramine Maleate)Assay | DTL, PuducherryState lab |
| DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE SYRUP | AA24004AMfg 2024-11 · Exp 2026-10 | Bengene Life Sciences Pvt. Ltd. R.S.No.: 239/2 | Incorrect labellingLabelling | DTL, PuducherryState lab |
| DEXTROMETHORPHAN HYDROBROMIDE 10mg, CHLORPHENIRAMINE MALEATE 2mg WITH PHENYLEPHRINE HYDROCHLORIDE 5 mg SYRUP | TZ0L-022Mfg 2025-05 · Exp 2027-04 | Tanmed Pharma (I) Pvt LtdTamil Nadu | Assay (for Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride )Assay | DTL, PuducherryState lab |
| Cyproheptadine Hydrochloride Syrup IP | SR-086Mfg 2024-12 · Exp 2026-11 | Sresan Pharmaceuticals ManufacturerKarnataka | The smple fails in the test PH and AssayAssay | RDTL ErnakulamState lab |
| Cyproheptadine Hydrochloride Syrup | SR-46Mfg 2025-08 · Exp 2027-07 | Sresan Pharmaceutical ManufacturerKarnataka | pHpH | Drugs Testing Laboratory, Chennai-06State lab |
| Cyclopam | 24070676Mfg 2024-12 · Exp 2026-05 | Indoco Remedies Ltd B-20Maharashtra | "The sample does not conform to I.P 2022 requirements with respect to the test for uniformity of weight."Uniformity of weight/content | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Cufcott LS Cough Syrup | CL230203EMfg 2023-12 · Exp 2025-11 | Condour PharmaceuticalsHimachal Pradesh | Content of LevosalbutamolOther | SDT&RL, BhubaneswarState lab |
| Compound Sodium Lactate Injection I.P. | 03B3911Mfg 2023-06 · Exp 2026-05 | Paschim Banga Pharmaceutical NH-31 | The sample does not comply as per I.P. 2022 with respect to the test for "Sterility".Sterility | RDTL, GuwahatiCDSCO lab |
| Colistimithate Sodium for Injection IP | LT25001Mfg 2025-08 · Exp 2027-07 | Maan Pharmaceuticals Ltd | Bacterial EndotoxinsBacterial endotoxins | Food & Drugs Laboratory, VadodaraState lab |
| Closantel I.P. 15% W/v & Ivermectin I.P 0.3% W/v Solution | CIG00625Mfg 2025-07 · Exp 2027-06 | Stanmax Laboratories Pvt. LtdTelangana | Identification and Assay for IvermectinAssay | DTL, Bengaluru, KarnatakaState lab |
| Clopidogrel and Aspirin Capsules (75mg +75mg | HSP25006Mfg 2025-02 · Exp 2027-01 | Hetero Labs LimitedPuducherry | Related substancesRelated substances | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel & Aspirin Tablets IP(75mg/75mg) | GT250375Mfg 2025-02 · Exp 2027-01 | Theon Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to IP Standards with respect to Related Substances of Aspirin and Description.Description | DTL ThrissurState lab |
| Clopidogrel & Aspirin Tablets | T250139Mfg 2025-01 · Exp 2026-12 | Ikon Pharmachem Pvt. LtdUttarakhand | The sample does not conform to IP Standards with respect to Dissolution, Related Substances and Assay of Aspirin Standards.Assay | DTL ThrissurState lab |
| Clarithromycin Oral Suspension USP | PGD4075AMfg 2024-12 · Exp 2026-11 | Plena RemediesHimachal Pradesh | Test for pH and Assay for ClarithromycinAssay | DTL, Bengaluru, KarnatakaState lab |
| Ciprofloxacin Tablets U.S.P. 500 mg.. | T-2408090Mfg 2024-08 · Exp 2026-07 | Rivpra Formulation Pvt. Ltd. Plot No.8Uttarakhand | The sample does not conform to claim as per U.S.P. with respect to the test for "Dissolution" of Ciprofloxacin.Dissolution | RDTL, GuwahatiCDSCO lab |
| Ciprofloxacin Hydrochloride Tablets IP 500 mg | JKBD24080Mfg 2024-08 · Exp 2027-07 | Cadila Pharmaceuticals Ltd | The sample does not conform to IP Standards, It fails the test ' Dissolution' as per IP.Dissolution | DTL ThiruvananthapuramState lab |
| Ciprofloxacin Hydrochloride Tablet IP 500 mg | CDA24002Mfg 2024-10 · Exp 2026-09 | Danish Health Care (P) Ltd | Test for DissolutionDissolution | RDTL, Hubli, KarnatakaState lab |
| Ciprofloxacin Hydrochloride & Tinidazole Bolus | CF2523Mfg 2025-03 · Exp 2027-02 | Rudraksha BioceuticalsGujarat | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| Cetirizine Hydrochloride, Phenylephrine Hydrochloride and Dextromethorphan Hydrobromide Syrup | R25053101Mfg 2025-02 · Exp 2027-01 | Shreya Lifesciences Pvt. Ltd. 13Uttarakhand | The sample does not conform as per I.P. 2022 with respect to the test for Diethylene Glycol (DEG).Other | RDTL, GuwahatiCDSCO lab |
| Ceftriaxone & Sulbactam Injection | SKY-19Mfg 2024-12 · Exp 2026-11 | Argon Remedies Pvt. LtdUttarakhand | Sterility for Sterile Water for InjectionSterility | DTL, Bengaluru, KarnatakaState lab |
| Cefixime and Lactic Acid Bacillus Dispersible Tablets | TB020Mfg 2024-10 · Exp 2026-09 | Titanes Pharma Vill. BathuHimachal Pradesh | Samples does not comply Assay of Cefixime as per STP.Assay | DCL TelanganaState lab |
| Cefixime Oral suspension IP | DS250075Mfg 2025-06 · Exp 2027-05 | Agron Remedies Pvt Ltd. Sarverkhera | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Cefixime Dispersible Tablets IP 200mg ) | CBEL24012Mfg 2024-03 · Exp 2026-02 | Curetech Formulation (P) Ltd. Vill. Juddi kalanHimachal Pradesh | Test for Uniformity of WeightUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab |
| Cefixime Dispersible Tablets IP | BT2506033Mfg 2025-06 · Exp 2027-05 | Shri Ramesth IndustriesHimachal Pradesh | Cefixime content 20.54 %Other | Food & Drugs Laboratory, VadodaraState lab |
| Cefipodoxime Proxetil Dispersible Tablets | CT25035GMfg 2025-05 · Exp 2027-04 | Curehealth Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to the IP with respect to ColourDescription | DTL, JaipurState lab |
| Calcium and Vitamin D3 Tablets IP (500mg+250 IU) (Calcium 500mg & Vitamin D3 250 IU) | T572514Mfg 2025-02 · Exp 2026-07 | Bengal Chemicals and Pharmaceuticals Ltd At:IIWest Bengal | This particular batch of sample fails the test 'Dissolution' as per IP.Dissolution | DTL ThrissurState lab |
| Calcium and Vitamin D3 Tablets IP (500mg+250 IU) | T572513Mfg 2025-02 · Exp 2026-07 | Bengal Chemicals & Pharmaceuticals Ltd. At 11Haryana | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution of CalciumDissolution | RDTL,ChandigarhCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 5ANL035Mfg 2025-02 · Exp 2026-07 | Yacca Life Sciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL076Mfg 2024-08 · Exp 2026-01 | Yacca Life Sciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL063Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL080Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL078Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL081Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL064Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL083Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL065Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL082Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL073Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL079Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL041Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL075Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL077Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. LtdUttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Phosphate & Vitamin D3 Suspension | 4ATL042Mfg 2024-08 · Exp 2026-01 | Yacca Lifesciences Pvt. Ltd. 156Uttarakhand | The sample does not conform to claim with respect to Microbial contamination test in regard to Total Aerobic viable count.Microbial limits | CDL, KolkataCDSCO lab |
| Calcium Carbonate Tablets IP | 3B1181Mfg 2025-06 · Exp 2027-05 | Deep PharmaGujarat | Dissolution (Calcium)Dissolution | Food & Drugs Laboratory, VadodaraState lab |
| Calcitriol, Calcium Carbonate, Zinc Oxide, Magnesium Oxide, Vitamin K27, Methylcobalamin & L-Methylfolate Soft Gelatin Capsules | D242039GMfg 2024-08 · Exp 2026-07 | Sigma Softgel & FormulationHimachal Pradesh | Test for Disintegration onlyDisintegration | RDTL, Hubli, KarnatakaState lab |
| CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE & PHENYLEPHRINE HYDROCHLORIDE SYRUP | RLRFDC016Mfg 2025-02 · Exp 2027-01 | .M/s Rosefinch Pharmaceutique Pvt LtdGujarat | Assay (for Chlorpheniramine Maletae)Assay | DTL, PuducherryState lab |
| CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE SYRUP IP | RRM-557Mfg 2025-08 · Exp 2027-07 | Redner FormulationsPuducherry | Assay (for Chlorpheniramine Maleate And Phenylephrine Hydrochloride )Assay | DTL, PuducherryState lab |
| Bupivacaine Injection IP | L2022410BMfg 2024-10 · Exp 2026-09 | Protech Telelinks Mouza OgliHimachal Pradesh | The sample does not conform to IP with respect to test for 'Particulate Matter' and is also not of standard quality for the reason stated under "Description".Description | CDL, KolkataCDSCO lab |
| Bromhexine Hydrochloride Syrup 4mg/5mL | L25/0111AMfg 2025-05 · Exp 2027-04 | SAMKEM 15-B & 10-BMadhya Pradesh | The sample received does not conform to manufactures specification with respect to the test for assay only.Assay | CDTL,HyderabadCDSCO lab |
| Beclomethasone Dipropionate & Clotrimazole Cream | 614Mfg 2024-09 · Exp 2026-08 | BCL PharamaHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Azithromycin Tablets IP 500 mg. | AYC-2407Mfg 2024-01 · Exp 2025-12 | Apple Formulations Pvt. LtdUttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Azithromycin.Dissolution | RDTL, GuwahatiCDSCO lab |
| Azithromycin Oral Suspension I.P. | JL-2469Mfg 2025-02 · Exp 2027-01 | Jainsons Healthcare Plot No.32Uttarakhand | The sample received does not conform to I.P. 2022 with respect to the test for AssayAssay | CDTL, MumbaiCDSCO lab |
| Atropine Sulphate Ophthalmic Solution USP 1% | AP-120Mfg 2024-12 · Exp 2026-11 | Sayora Pharma Private Ltd. Plot No. 28Haryana | The sample received does not conform to I.P. 2022 with respect to the test for Relatee substances.Other | CDTL, MumbaiCDSCO lab |
| Atorvastatin and Clopidogrel Capsules | K2501777Mfg 2025-07 · Exp 2027-06 | Intas Pharmaceuticals Ltd BagheykholaSikkim | The sample does not conform to claim with respect to Assay of Atorvastatin.Assay | CDL, KolkataCDSCO lab |
| Atorvastatin Tablets IP 10mg | RT-250560Mfg 2025-05 · Exp 2027-04 | Relief Biotech Pvt. LtdDelhi | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Atorvastatin Calcium Tablets IP 40 mg | ART-07Mfg 2024-04 · Exp 2026-03 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | RDTL,ChandigarhCDSCO lab |
| Atorvastatin & Clopidogrel Tablets | MT251814Mfg 2025-06 · Exp 2027-05 | Mascot Health Series Pvt. Ltd. Plot No. 79&80 Sector 6AUttarakhand | The sample received does not conform to Manufacturers specification with respect to the test of Atorvasatin assay.Assay | CDTL, MumbaiCDSCO lab |
| Anti Dandruff Shampoo with Conditioner, | BC190Mfg 2025-07 · Exp 2028-06 | Morvin India Health Care Pvt. Ltd. 11Gujarat | The sample does not conform to Manufacturer specification with respect to the test for "Determination of pH value".pH | CDTL, MumbaiCDSCO lab |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets | 24KHBT-0194Mfg 2024-10 · Exp 2026-03 | Kaalinga HealthcareHimachal Pradesh | The content of Clavulanic Acid in the sample is less (i.e. 26.94% of the labelled amount than the Schedule V Limit. Schedule V Limit 90% to 130% of Labelled AmountLabelling | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| Amoxycillin for Injection IP | AMK-18Mfg 2024-12 · Exp 2026-11 | Argon Remedies Pvt. LtdUttarakhand | Sterility for Sterile Water for InjectionSterility | DTL, Bengaluru, KarnatakaState lab |
| Amoxycillin & Potassium Clavulanate oral suspension IP | NBD020AMfg 2025-02 · Exp 2026-07 | Nexkem Biotech Pvt.Ltd Plot No.64Himachal Pradesh | The sample does not comply with the test for Assay of Amoxycillin and Clavulanic Acid and hence it is Not of Standard Quality.Assay | DCL TelanganaState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP (500 mg + 125 mg) | SH240051Mfg 2024-09 · Exp 2026-08 | Sotac Healthcare Private LimitedGujarat | The sample does not conform to standard quality in respect of the test for "Assay & Dissolution" performed.Assay | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| Amoxycillin & Potassium Clavulanate & Lactic Acid Bacillus Tablets | MYRTAB-883Mfg 2025-01 · Exp 2026-06 | Mayer Lab chambagat Adjesent to Railway crossingHimachal Pradesh | Assay for Clavulanic Acid does not complies as per STP. Uniformity of Weight does not complies as per IP Specifications, since three tablets deviated lower limit ie.95% and three tablets deviated higher limit percentage ie. 105%Assay | DCL TelanganaState lab |
| Amoxycillin & Potassium Clavulanate Tablets I.P | MICTAB-2424Mfg 2025-06 · Exp 2026-11 | Micro FormulationsHimachal Pradesh | Test for Dissolution and Assay for Amoxycillin & Potassium ClavulanateAssay | RDTL, Bellary, KarnatakaState lab |
| Amlodipine Tablets IP 5mg | RT-2505104Mfg 2025-05 · Exp 2027-04 | Relief Biotech Pvt. LtdDelhi | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Amitriptyline Tablets IP 25mg | GAMT2Mfg 2025-06 · Exp 2027-05 | Super formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Tablets IP 25 mg | AMT1305Mfg 2025-05 · Exp 2027-04 | Unicure India LtdUttar Pradesh | UniformityUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Tablets IP 25 mg | GAMT1Mfg 2025-05 · Exp 2027-04 | Super formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amitriptyline Tablets IP | DRT25096Mfg 2025-04 · Exp 2027-03 | Eastern Healthcare Plot No.7Uttarakhand | The sample does not conform to claim as per IP 2022 in respect to the Test of DescriptionDescription | RDTL,ChandigarhCDSCO lab |
| Ambroxol, Levosalbutamol and Guaiphenesin Syrup, | BM24022Mfg 2025-06 · Exp 2027-05 | Bio Neutraceuticals D.no.8-290/1 | The sample received does not conform to manufacturer's specification with respect to the test for Ph only.pH | CDTL,HyderabadCDSCO lab |
| Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate and Menthol Syrup | 24338Mfg 2024-11 · Exp 2026-10 | Zeta Formulation Private Limited | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol HCl, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup) | XL1625Mfg 2024-11 · Exp 2026-10 | Saphnix Life Sciences (A WHO-GMPHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ambroxol HCL, Levosalbutamol and Guaiphenesin Syrup | IQ-337CMfg 2025-03 · Exp 2027-02 | Go-ish Remedies Limited (Unit-II)Himachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Aluminium, Magnesium and Simethicone Oral Suspension IP | L25/0172AMfg 2025-06 · Exp 2027-05 | SamkemMadhya Pradesh | General DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Aluminium Hydroxide, Magnesium Hydroxide and Simethicone Oral Suspension IP | ECL/25/026Mfg 2025-04 · Exp 2027-03 | Emmchak Formulations Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Alprazolam Tablets IP (0.5 mg) | 3332Mfg 2024-05 · Exp 2027-04 | Reliance Formulation Pvt. Ltd. 7/2-AGujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | RDTL,ChandigarhCDSCO lab |
| Adrenochrome Monosemicarbazone 1mg | CA025005Mfg 2025-06 · Exp 2028-05 | Life Pharmaceuticals Pvt. Ltd. 53(P) And 54(P) Uluberia Industrial Growth Centre Howrah-711316West Bengal | The sample does not conform to claim with respect to test for 'Particulate matter', and 'Description'.Description | CDL, KolkataCDSCO lab |
| Aceclofenac & Paracetamol Tablets | GT16375AMfg 2024-11 · Exp 2026-10 | J M LaboratoriesHimachal Pradesh | It fails the test Dissolution and Assay as per IP.Assay | RDTL ErnakulamState lab |
| ASPIRIN TABLETS I.P. 75 MG | 241271Mfg 2024-12 · Exp 2027-11 | Modi AntibioticsGujarat | 1) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets.2 ) The Content of Aspirin in the Sample is less (i.e. 69.84% of Stated amount) than the IP Limits. (IP Limit - Not less than 95% and Not more than 105% of stated Amount)Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| ASPIRIN TABLETS I.P. 75 MG | 240604Mfg 2024-06 · Exp 2027-05 | Modi AntibioticsGujarat | 1 ) The Sample does not Comply for Description as White Circular Powdery Tablets which are too brittle in nature shows needle shaped Crystals in all the blister Packets. 2 )The Sample does not give IP Identification for the Presence of Aspirin. 3 ) The Sample gives additional Identification for the Presence of Salicylic Acid. 4 ) Found Content of Salicylic Acid in the Sample is 73.68 mg/Tablet.Description | FDA, Lab, M.S Chhatrapati Sambhaji Nagar Maharashtra StateState lab |
| AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN AND MENTHOL SYRUP | CL-24083Mfg 2024-12 · Exp 2026-11 | Casid Pharmaceuticals Private LimitedTamil Nadu | Incorrect labellingLabelling | DTL, PuducherryState lab |
| ALBENDAZOLE TABLETS I.P. 400 mg | FGT7J502Mfg 2025-09 · Exp 2028-08 | ZIM LABORATORIES LIMITEDMaharashtra | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| ALBENDAZOLE TABLETS I.P. 400 mg | FGT7J501Mfg 2025-09 · Exp 2028-08 | ZIM LABORATORIES LIMITEDMaharashtra | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab |
| (Povidone Iodine Ointment USP 5% W/W) | ADE25105Mfg 2025-01 · Exp 2026-12 | Astonea Labs LtdHaryana | Assay for Available IodineAssay | DTL, Bengaluru, KarnatakaState lab |
| (Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup) | VS2523Mfg 2025-07 · Exp 2027-06 | Vertex Pharma ChemicalsPuducherry | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| (Clobetasol Propionate & Salicylic Acid Ointment ) | 5550Mfg 2025-07 · Exp 2027-06 | Canixa Life Sciences Pvt. LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| (Ambroxol Hydrochloride, Salbutamol, Guaifenesin and Menthol) | XL002Mfg 2023-02 · Exp 2026-01 | Intermed Laboratories Private LimitedTamil Nadu | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant Tablets IP (PAN 40) | 24440478 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telmisartan Tablets I.P. 40 mg (Telma 40) | 18240413 | Under Investigation | RDTL,Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (216 rows). Revised CDSCO lists are diffed on each monthly rebuild.